Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma
- PMID: 25316178
- PMCID: PMC4268072
- DOI: 10.1016/j.ygyno.2014.10.005
Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma
Abstract
Objective: To determine the effect of excisional tubal sterilization on subsequent development of serous epithelial ovarian cancer (EOC) or primary peritoneal cancer (PPC).
Methods: We performed a population-based, nested case-control study using the Rochester Epidemiology Project. We identified all patients with a diagnosis of serous EOC or PPC from 1966 through 2009. Each case was age-matched to 2 controls without either diagnosis. Odds ratios (ORs) and corresponding 95% CIs were estimated from conditional logistic regression models. Models were adjusted for prior hysterectomy, prior salpingo-oophorectomy, oral contraceptive use, endometriosis, infertility, gravidity, and parity.
Results: In total, we identified 194 cases of serous EOC and PPC during the study period and matched them with 388 controls (mean [SD] age, 61.4 [15.2] years). Fourteen cases (7.2%) and 46 controls (11.9%) had undergone tubal sterilization. Adjusted risk of serous EOC or PPC was slightly lower after any tubal sterilization (OR, 0.59 [95% CI, 0.29-1.17]; P=.13). The rate of excisional tubal sterilization was lower in cases than controls (2.6% vs 6.4%). Adjusted risk of serous EOC and PPC was decreased by 64% after excisional tubal sterilization (OR, 0.36 [95% CI, 0.13-1.02]; P=.054) compared with those without sterilization or with nonexcisional tubal sterilization.
Conclusions: We present a population-based investigation of the effects of excisional tubal sterilization on the risk of serous EOC and PPC. Excisional methods may confer greater risk reduction than other sterilization methods.
Keywords: Fimbriectomy; Salpingectomy; Serous ovarian cancer; Serous primary peritoneal cancer; Tubal sterilization.
Copyright © 2014 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors report no conflict of interest.
Similar articles
-
Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.Acta Obstet Gynecol Scand. 2015 Jan;94(1):86-94. doi: 10.1111/aogs.12516. Epub 2014 Oct 17. Acta Obstet Gynecol Scand. 2015. PMID: 25256594
-
Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.Int J Cancer. 2013 Nov 15;133(10):2415-21. doi: 10.1002/ijc.28249. Epub 2013 Jul 9. Int J Cancer. 2013. PMID: 23650079 Free PMC article.
-
Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-A nationwide case-control study.Int J Cancer. 2021 Oct 15;149(8):1544-1552. doi: 10.1002/ijc.33714. Epub 2021 Jul 7. Int J Cancer. 2021. PMID: 34152012
-
Molecular genetics and epidemiology of epithelial ovarian cancer (Review).Oncol Rep. 2011 Dec;26(6):1347-56. doi: 10.3892/or.2011.1456. Epub 2011 Sep 12. Oncol Rep. 2011. PMID: 21922146 Review.
-
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.Am J Epidemiol. 2017 Jan 1;185(1):8-20. doi: 10.1093/aje/kww161. Epub 2016 Dec 9. Am J Epidemiol. 2017. PMID: 27941069 Free PMC article. Review.
Cited by
-
Risk-reducing salpingectomy: Let us be opportunistic.Cancer. 2017 May 15;123(10):1714-1720. doi: 10.1002/cncr.30528. Epub 2017 Mar 23. Cancer. 2017. PMID: 28334425 Free PMC article. Review.
-
Ovarian cancer risk reduction by salpingectomy during non-gynaecological surgery: scoping review.BJS Open. 2024 Dec 30;9(1):zrae161. doi: 10.1093/bjsopen/zrae161. BJS Open. 2024. PMID: 39871731 Free PMC article.
-
High-grade serous ovarian cancer 3 years after bilateral salpingectomy: A case report.Mol Clin Oncol. 2017 Feb;6(2):201-203. doi: 10.3892/mco.2016.1105. Epub 2016 Dec 12. Mol Clin Oncol. 2017. PMID: 28357094 Free PMC article.
-
Implementation of opportunistic salpingectomy for ovarian cancer prevention: Analyzing clinical practice and key characteristics.Acta Obstet Gynecol Scand. 2025 Aug;104(8):1539-1549. doi: 10.1111/aogs.15128. Epub 2025 Jun 5. Acta Obstet Gynecol Scand. 2025. PMID: 40470705 Free PMC article.
-
Salpingectomy and the Risk of Ovarian Cancer in Ontario.JAMA Netw Open. 2023 Aug 1;6(8):e2327198. doi: 10.1001/jamanetworkopen.2023.27198. JAMA Netw Open. 2023. PMID: 37566421 Free PMC article.
References
-
- Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014 Jan;64(1):9–29. Epub 2014 Jan 7. - PubMed
-
- Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134–47. Epub 2011 Dec 5. - PMC - PubMed
-
- Pennington KP, Swisher EM. Hereditary ovarian cancer: beyond the usual suspects. Gynecol Oncol. 2012 Feb;124(2):347–53. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical